ALX Oncology Holdings Inc. (ALXO) vs Voyager Therapeutics, Inc. (VYGR)
A side-by-side comparison of ALX Oncology Holdings Inc. and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VYGR
Voyager Therapeutics, Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALXO vs VYGR
growth of $100 · dividends reinvested · last 6yALXO -96.0% (-41.4%/yr)VYGR -81.0% (-24.2%/yr)VYGR compounded faster over this window
ALXO VYGR
ALXO vs VYGR: by the numbers
- •ALXO is the larger company ($149M vs $149M market cap).
- •Both run net losses; ALXO's is the smaller (0.00% vs -312.63% net margin).
Metrics side by side
Valuation
| Metric | ALXO | VYGR |
|---|---|---|
| P/S ratio | N/A | 4.31 |
| P/B ratio | 1.10 | 0.96 |
Profitability
| Metric | ALXO | VYGR |
|---|---|---|
| Gross margin | 0.00% | -227.62% |
| Operating margin | 0.00% | -326.56% |
| Net margin | 0.00% | -312.63% |
| ROE | -59.40% | -69.78% |
| ROIC | -56.53% | -64.72% |
Growth (annualized)
| Metric | ALXO | VYGR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -23.59% |
| Total return CAGR (5Y) | -56.07% | -0.08% |
Frequently asked
- How have ALXO and VYGR total returns compared?
- Over the past 5 years, ALXO delivered -56.07% and VYGR delivered -0.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.